Matuzumab

Matuzumab is a humanized monoclonal antibody with antineoplastic activity. Matuzumab binds the epidermal growth factor receptor (EGFR) with high affinity, competitively blocking natural ligand binding and inhibiting receptor-mediated downstream signalling, resulting in impaired tumor cell proliferation. The directory classifies it as a discontinued API with a biotechnology source/manufacturing origin. Other names for this substance include DTXSID301053205, EMD 72000 and matuzumabum. Its PubChem SID is 505806396.

CAS No 339186-68-4
Molecular Formula N/A
Molecular Weight ~150 kDa
Synonyms N/A

Frequently Asked Questions